| Gene expression levels and immunolocalization of organic ion transporters in the human kidney H Motohashi, Y Sakurai, H Saito, S Masuda, Y Urakami, M Goto, ... Journal of the American Society of Nephrology 13 (4), 866-874, 2002 | 590 | 2002 |
| Cellular and molecular aspects of drug transport in the kidney KI Inui, S Masuda, H Saito Kidney international 58 (3), 944-958, 2000 | 536 | 2000 |
| Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters Y Tanihara, S Masuda, T Sato, T Katsura, O Ogawa, K Inui Biochemical pharmacology 74 (2), 359-371, 2007 | 441 | 2007 |
| Identification and functional characterization of a new human kidney–specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2 S Masuda, T Terada, A Yonezawa, Y Tanihara, K Kishimoto, T Katsura, ... Journal of the American Society of Nephrology 17 (8), 2127-2135, 2006 | 427 | 2006 |
| Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1–3 and multidrug and toxin extrusion family) A Yonezawa, S Masuda, S Yokoo, T Katsura, K Inui Journal of Pharmacology and Experimental Therapeutics 319 (2), 879-886, 2006 | 382 | 2006 |
| Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney T Mikkaichi, T Suzuki, T Onogawa, M Tanemoto, H Mizutamari, M Okada, ... Proceedings of the national Academy of sciences 101 (10), 3569-3574, 2004 | 331 | 2004 |
| Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer Y Togashi, K Masago, S Masuda, T Mizuno, M Fukudo, Y Ikemi, ... Cancer chemotherapy and pharmacology 70, 399-405, 2012 | 292 | 2012 |
| Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs Y Urakami, M Okuda, S Masuda, H Saito, KI Inui Journal of Pharmacology and Experimental Therapeutics 287 (2), 800-805, 1998 | 268 | 1998 |
| Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity S Yokoo, A Yonezawa, S Masuda, A Fukatsu, T Katsura, KI Inui Biochemical pharmacology 74 (3), 477-487, 2007 | 259 | 2007 |
| C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation M Goto, S Masuda, H Saito, S Uemoto, T Kiuchi, K Tanaka, K Inui Pharmacogenetics and Genomics 12 (6), 451-457, 2002 | 256 | 2002 |
| An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients S Masuda, K Inui Pharmacology & therapeutics 112 (1), 184-198, 2006 | 246 | 2006 |
| Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney H Saito, S Masuda, K Inui Journal of Biological Chemistry 271 (34), 20719-20725, 1996 | 238 | 1996 |
| CYP3A5* 1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation M Goto, S Masuda, T Kiuchi, Y Ogura, F Oike, M Okuda, K Tanaka, K Inui Pharmacogenetics and Genomics 14 (7), 471-478, 2004 | 230 | 2004 |
| Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells M Tsuda, T Terada, M Ueba, T Sato, S Masuda, T Katsura, K Inui Journal of Pharmacology and Experimental Therapeutics 329 (1), 185-191, 2009 | 201 | 2009 |
| Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat A Yonezawa, S Masuda, K Nishihara, I Yano, T Katsura, K Inui Biochemical pharmacology 70 (12), 1823-1831, 2005 | 198 | 2005 |
| Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts A Miyagawa-Hayashino, A Yoshizawa, Y Uchida, H Egawa, K Yurugi, ... Liver Transplantation 18 (11), 1333-1342, 2012 | 182 | 2012 |
| Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients M Uesugi, S Masuda, T Katsura, F Oike, Y Takada, K Inui Pharmacogenetics and genomics 16 (2), 119-127, 2006 | 181 | 2006 |
| Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy L Ji, S Masuda, H Saito, KI Inui Kidney international 62 (2), 514-524, 2002 | 167 | 2002 |
| Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living‐donor liver transplantation T Hashida, S Masuda, S Uemoto, H Saito, K Tanaka, K Inui Clinical Pharmacology & Therapeutics 69 (5), 308-316, 2001 | 165 | 2001 |
| Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney S Masuda, K Ibaramoto, A Takeuchi, H Saito, Y Hashimoto, KI Inui Molecular Pharmacology 55 (4), 743-752, 1999 | 160 | 1999 |
